number
diseas
import
global
term
effect
livestock
develop
recombin
plantproduc
vaccin
preliminari
mani
diseas
bovin
viral
diarrhoea
bvd
bovin
rotaviru
brv
bovin
herp
boh
transmiss
gastroenter
tge
pig
infecti
bronchiti
ib
chicken
bluetongu
bt
sheep
rift
valley
fever
rvf
sheep
coccidiosi
chicken
commerci
avail
liveattenu
kill
vaccin
avail
although
effect
vari
degre
numer
issu
manufactur
potenti
reassort
vaccin
strain
diseas
bovin
papillomaviru
bpv
infect
crimeancongo
haemorrhag
fever
cchf
commerci
avail
vaccin
limit
studi
conduct
develop
chapter
discuss
research
develop
plantproduc
vaccin
candid
potenti
develop
toward
commercialis
protein
capsid
protein
c
e
rn
envelop
glycoprotein
rnase
two
extern
glycoprotein
choi
et
al
persist
cattl
caus
rang
immunosuppress
symptom
well
affect
respiratori
function
fertil
lanyon
et
al
lead
herd
morbid
subsequ
financi
impact
farmer
livestock
economi
particular
variant
bvd
caus
mucos
diseas
transmit
utero
foetu
antibodyneg
mother
antibodyneg
anim
refer
persist
infect
pi
pi
anim
show
symptom
bvd
shed
larg
amount
viru
young
often
succumb
diseas
make
desir
termin
anim
brock
et
al
transmiss
bvdv
occur
vertic
horizont
aerosol
fecalor
rout
viru
usual
enter
mucos
tissu
line
mouth
nose
replic
epitheli
tissu
spread
via
blood
stream
enter
type
tissu
cell
use
rout
lanyon
et
al
current
use
vaccin
compris
modifiedl
virus
mlv
kill
viru
kv
mlv
prefer
give
broader
longer
last
effect
disadvantag
use
induct
post
vaccin
mucos
diseas
immunosuppress
ridpath
immun
induc
recommend
vaccin
programm
herd
level
effect
problem
heterogen
viru
lead
genet
drift
subsequ
variat
strain
led
constant
demand
new
vaccin
strain
turn
led
research
look
develop
recombin
vaccin
fulton
recombin
vaccin
bvdv
focuss
major
glycoprotein
viru
shown
immunogen
induc
neutralis
antibodi
ridpath
recombin
modif
provid
cattl
protect
bvdv
produc
anim
cell
pecora
et
al
thoma
et
al
also
work
carri
develop
recombin
vaccin
product
plant
nelson
et
al
clone
truncat
version
immunogen
protein
n
tabacum
protein
accumul
per
gram
fresh
leav
serum
guinea
pig
immunis
subcutan
dose
mix
adjuv
show
presenc
neutral
antibodi
addit
aguirreburuald
et
al
made
transgen
alfalfa
plant
produc
recombin
fusion
protein
fuse
singl
chain
variabl
fragment
scfv
target
protein
antigen
present
cell
protein
yield
fresh
weight
report
immunogen
evalu
serum
guinea
pig
immunis
intramuscularli
leaf
extract
contain
recombin
show
induct
strong
neutralis
antibodi
respons
addit
cattl
immunis
intramuscularli
dose
product
also
show
neutralis
antibodi
respons
subsequ
complet
protect
infect
challeng
live
viru
interestingli
gao
et
al
develop
transgen
ginseng
hairi
root
cultur
express
bvdv
glycoprotein
rn
sika
deer
immunis
subcutan
transgen
hairi
root
extract
serum
shown
contain
antibodi
also
specif
cellmedi
respons
induc
measur
increas
phytohaemagglutinininduc
lymphocyt
prolifer
bovin
papillomaviru
caus
group
doublestrand
dna
bovin
papillomavirus
bpv
belong
famili
papillomavirida
type
describ
date
munday
dna
encod
viral
oncoprotein
well
two
structur
protein
form
virion
capsid
chen
et
al
gener
bpv
shown
specif
bovin
report
infect
equid
well
bovin
hamad
et
al
viru
endem
worldwid
caus
benign
malign
tumour
infect
mucosa
squamou
epithelium
mesenchym
embryo
symptom
lead
loss
milk
product
infertil
immunosuppress
caus
declin
gener
anim
health
love
et
al
bpv
spread
cattl
direct
indirect
contact
also
transmit
insect
infect
thought
occur
microtrauma
subsequ
entri
variou
tissu
includ
cutan
mucos
epithelium
subsequ
disrupt
cell
life
cycl
effect
bpv
protein
munday
campo
et
al
show
prophylact
vaccin
anim
live
bpv
stimul
product
neutralis
antibodi
provid
complet
protect
live
viru
challeng
group
research
also
show
subunit
vaccin
compris
antigen
provid
effect
prophylaxi
result
product
neutralis
antibodi
protect
anoth
research
group
describ
vaccin
calv
induc
viru
neutralis
antibodi
subsequ
protect
infect
challeng
borzacchiello
roperto
coexpress
alon
mammalian
cell
result
assembl
viruslik
particl
vlp
immunogen
stimul
neutralis
antibodi
provid
protect
kirnbauer
et
al
despit
commerci
avail
vaccin
bpv
yet
product
recombin
vaccin
plant
would
appeal
abrog
possibl
contamin
anim
deriv
protein
high
steril
tissu
cultur
condit
requir
love
et
al
test
product
bpv
vlp
plant
shown
similar
vlp
express
transient
n
benthamiana
infiltr
agrobacterium
harbour
clone
peaqht
plant
express
vector
yield
report
mgkg
fresh
weight
rabbit
immunis
lg
vlp
mix
freund
incomplet
adjuv
produc
igg
rotaviru
infect
cattl
caus
doubl
strand
rna
viru
belong
rotaviru
genu
famili
reovirida
occur
worldwid
caus
acut
gastroenter
diarrhoea
particularli
young
anim
week
old
progress
increas
morbid
sever
enter
mortal
well
reduct
growth
rate
dhama
et
al
togeth
extens
treatment
cost
factor
lead
seriou
econom
loss
livestock
owner
affect
countri
although
clinic
sign
last
long
perman
outbreak
certain
season
often
occur
result
viral
shed
last
week
infect
virion
made
inner
core
mostli
capsid
protein
middl
layer
compris
abund
protein
protein
form
outer
layer
major
capsid
protein
highli
immunogen
contain
common
antigen
type
serogroup
papp
et
al
virion
stabl
environ
transmit
faecalor
rout
spread
viral
shed
faec
water
low
dose
requir
infect
adult
cattl
popul
gener
brv
posit
natur
occur
passiv
immunis
newborn
calv
common
oral
ingest
colostrum
milk
saif
fernandez
howev
modern
time
intens
farm
method
exposur
anim
high
concentr
viru
earli
wean
supplement
feed
calf
concentr
dilut
milk
antibodi
influenc
reduc
extent
immun
herd
lead
requir
vaccin
current
commerci
avail
brv
matern
vaccin
market
allow
parenter
immunis
femal
subsequ
facilit
passiv
immun
newborn
calv
vaccin
compris
attenuatedl
viral
strain
inactiv
viru
shown
stimul
increas
antibodi
product
mammari
secret
vaccin
femal
protect
feed
calv
brv
challeng
howev
limit
attenuatedl
vaccin
presenc
adventiti
agent
gradual
emerg
differ
serotyp
well
inactiv
vaccin
alter
immunogen
form
make
gener
recombin
vaccin
favour
also
develop
gener
recombin
brv
vaccin
form
vlp
et
al
abl
produc
rotaviru
vlp
consist
capsid
protein
baculoviru
express
system
product
brv
vlp
plant
seem
yield
greater
success
sever
exampl
research
develop
recombin
plantproduc
brv
vaccin
hammond
nemchinov
ruiz
et
al
dong
et
al
made
recombin
transgen
alfalfa
oral
gavag
mice
lg
purifi
adjuv
cpg
dong
et
al
serum
treat
mice
shown
igg
antibodi
iga
antibodi
isol
homogenis
small
intestin
faec
saliva
interestingli
pup
born
immunis
mice
subsequ
challeng
live
rotaviru
show
reduc
symptom
diarrhoea
reduc
intens
durat
diarrhoea
indic
immun
passiv
transfer
pup
anoth
studi
recombin
rotaviru
capsid
protein
express
chenopodium
amaranticolor
result
infect
engin
beet
black
scorch
viru
bbsv
zhou
et
al
partial
purifi
dose
plant
leaf
extract
contain
lg
cpg
adjuv
use
gavag
mice
analysi
mucos
iga
igg
titr
show
high
titr
compar
control
mice
pup
born
immunis
mice
challeng
rotaviru
show
signific
reduct
incid
sever
durat
diarrhoea
indic
plantproduc
provid
passiv
protect
rotaviru
et
al
describ
product
vlp
transgen
tomato
lycopersicon
esculentum
l
fruit
albeit
fairli
low
et
al
serum
mice
immunis
lyophilis
tomato
extract
contain
lg
rotaviru
protein
freund
adjuv
shown
contain
antibodi
protein
protect
studi
carri
yang
et
al
coexpress
rotaviru
transgen
tobacco
plant
protein
express
leav
combin
protein
result
assembl
vlp
oral
deliveri
semipurifi
prepar
vlp
administ
ct
adjuv
show
although
vaccin
candid
induc
rais
titr
rotavirusspecif
antibodi
iga
igg
mice
immunis
vlp
higher
titr
vlp
lentz
et
al
approach
rotaviru
vaccin
differ
test
express
lentz
et
al
one
outermost
capsid
protein
infect
cleav
produc
ntermin
nonglycosyl
sialic
acidrecognis
domainand
ctermin
fragment
remain
associ
virion
major
determin
viral
infect
one
neutralis
antigen
express
transplastom
tobacco
leav
shown
form
insolubl
aggreg
solubl
insolubl
fraction
crude
prepar
contain
lg
marcol
adjuv
use
immunis
mice
intraperiton
igg
antibodi
titr
mice
immunis
sampl
shown
induc
addit
immunogen
shown
induc
viru
neutralis
antibodi
also
shown
passiv
immunis
offspr
demonstr
presenc
high
level
igg
antibodi
pup
eighti
challeng
pup
protect
rotaviru
challeng
determin
absenc
diarrhoea
wigdorovitz
et
al
report
express
immunogen
peptid
neutralis
epitop
origin
transgen
alfalfa
fuse
serv
carrier
molecul
inject
intraperiton
dose
mice
crude
extract
adjuv
freund
incomplet
adjuv
contain
shown
induc
rotavirusspecif
antibodi
moreov
fresh
leav
contain
fed
oral
mice
week
time
rotavirusspecif
antibodi
shown
induc
mice
protect
oral
viru
challeng
matsamura
et
al
report
express
rotaviru
capsid
protein
transgen
potato
tuber
intraperion
immunis
mice
dose
adjuv
potato
tuber
extract
contain
ng
show
antibodi
stimul
posit
result
contribut
feasibl
produc
subunit
rotaviru
vaccin
plant
bovin
herp
viru
caus
worldwid
disord
cattl
refer
infecti
bovin
rhinotrach
bhv
doublestrand
dna
viru
belong
varicelloviru
genu
herpesvirida
famili
caus
extens
rang
symptom
includ
rhinotrach
infecti
pustular
vulvovagin
enter
gener
respiratori
diseas
enceph
decreas
milk
product
weight
loss
abort
pregnant
cow
great
concern
regard
caus
sever
econom
loss
graham
affect
adult
young
anim
boh
infect
anim
mucou
membran
either
upper
respiratori
genit
tract
muylken
et
al
transmiss
anim
requir
direct
contact
boh
virion
encod
glycoprotein
glycoprotein
gd
respons
permiss
host
cell
receptor
bind
other
respons
cell
entri
current
vaccin
employ
combat
viru
consist
inactiv
modifi
live
viru
van
drunen
shown
vaccin
efficaci
reduc
symptom
infect
challeng
challeng
viru
remain
latent
host
tissu
reactiv
subsequ
excret
therebi
erad
infect
herd
addit
efficaci
type
vaccin
neonat
efficaci
adult
anim
due
function
immatur
immun
system
difficulti
particular
mount
cellular
respons
boh
essenti
immun
led
develop
recombin
vaccin
subunit
vaccin
compris
glycoprotein
antigen
shown
excel
target
neutralis
antibodi
alv
dummer
et
al
express
baculoviru
adenoviru
mammalian
cell
cultur
system
muylken
et
al
perezfilguiera
et
al
express
glycoprotein
n
benthamiana
tmvbase
express
vector
mice
immunis
approxim
lg
crude
leaf
extract
mix
ifa
show
specif
humor
respons
glycoprotein
singl
dose
cattl
immunis
approxim
lg
crude
leaf
extract
also
show
specif
antibodi
respons
vaccin
addit
analysi
lymphocyt
pbmc
indic
posit
prolifer
indic
suggest
cellular
immun
respons
also
stimul
vaccin
secret
nasal
fluid
immunis
anim
subsequ
challeng
live
viru
show
similar
amount
viru
mice
period
viru
shed
cattl
day
indic
vaccin
protect
rinderpest
otherwis
known
cattl
plagu
caus
singlestrand
rna
morbilliviru
paramyxovirida
famili
rna
encod
phosphoprotein
p
nucleoprotein
n
polymeras
l
found
insid
virion
well
matrix
protein
form
outer
capsid
haemagglutinin
neuraminidas
hn
fusion
protein
f
form
outer
envelop
virion
martin
viru
highli
communic
spread
direct
contact
contamin
drink
water
sometim
aerosol
affect
mammal
includ
man
affect
mostli
ungul
symptom
characteris
fever
ocular
nasal
discharg
morbid
mortal
rate
high
primari
symptom
lead
oral
gastrointestin
tract
ulcer
dysenteri
diarrhoea
dehydr
lymphocyt
deplet
caus
protein
loss
immunosuppress
roeder
et
al
thought
rinderpest
origin
central
south
asia
result
human
activ
spread
europ
africa
rinderpest
viru
rv
replic
quickli
inactiv
quit
easili
heat
direct
sunlight
infect
target
lymphat
system
well
epitheli
cell
respiratori
system
gastrointestin
tract
oie
viru
move
quickli
symptom
seen
soon
three
day
post
infect
first
vaccin
develop
rinderpest
attenu
viru
cultur
bovin
kidney
cell
tissu
cultur
rinderpest
vaccinetcrv
extrem
success
combat
clade
viru
lifelong
immun
cattl
singl
dose
plowright
ferri
subsequ
temperatur
resist
vaccin
thermovax
develop
use
final
erad
rinderpest
roeder
et
al
lead
declar
final
global
erad
develop
recombin
vaccin
rinderpest
envelop
protein
h
haemagglutinin
f
fusion
express
cattl
immunis
disabl
human
adenoviru
vector
ad
vector
shown
result
express
rinderpestspecif
protein
stimul
product
neutralis
antibodi
subsequ
protect
cattl
infect
challeng
live
viru
cosbi
yamanouchi
prior
declar
final
erad
khandelw
et
al
describ
gener
transgen
peanut
plant
arachi
hypogea
l
express
rpv
h
protein
khandelw
et
al
mice
immunis
intraperiton
h
togeth
ifa
elicit
hspecif
antibodi
neutralis
viru
vitro
oral
immunis
mice
elicit
hspecif
igg
iga
antibodi
group
carri
oral
immunis
cattl
transgen
peanut
leav
express
h
protein
serum
immunis
cattl
shown
contain
hspecif
antibodi
well
neutralis
crossneutralis
activ
around
transmiss
gastroenter
highli
contagi
diseas
caus
sever
acut
diarrhoea
newborn
piglet
result
high
mortal
rate
less
twoweek
old
anim
saif
et
al
caus
transmiss
gastroenter
viru
tgev
singlestrand
rna
viru
belong
coronaviru
genu
famili
coronavirida
widespread
caus
sever
econom
loss
pig
farmer
viru
infect
enterocyt
small
intestin
multipli
caus
enter
oie
protein
integr
membran
protein
gs
spike
glycoprotein
occur
surfac
virion
laud
et
al
current
commerci
avail
vaccin
use
treat
tgev
modifi
live
viru
gs
glycoprotein
respons
induc
neutralis
antibodi
howev
develop
progress
recombin
vaccin
produc
mammalian
express
vector
shown
promot
system
mucos
immun
well
passiv
immun
suckl
piglet
hammond
nemchinov
also
sever
exampl
plantproduc
protein
test
vaccin
tgev
et
al
made
transgen
arabidopsi
encod
fulllength
gs
protein
ntermin
domain
gs
shown
neutralis
ng
serum
mice
inocul
protein
show
virusspecif
neutralis
immunoprecipit
vitro
et
al
also
made
transgen
potato
plant
express
ng
tuber
extract
inocul
mice
induc
tgevspecif
igg
oral
immunis
mice
antigen
also
shown
stimul
serum
antibodi
specif
gs
tuboli
et
al
similarli
express
truncat
tgev
protein
region
express
transgen
tobacco
immunis
pig
show
tgevspecif
immun
respons
lamphear
et
al
lamphear
et
al
describ
product
oral
tgev
vaccin
candid
produc
corn
mill
fed
pig
boost
antibodi
level
serum
colostrum
milk
infecti
bronchiti
young
chicken
acut
highli
contagi
respiratori
diseas
caus
infecti
bronchiti
viru
ibv
gamma
coronaviru
belong
famili
coronavirida
jackwood
apart
affect
upper
respiratori
tract
also
affect
reproduct
tract
strain
caus
nephriti
infect
caus
weight
loss
decreas
egg
product
gener
poor
perform
flock
high
morbid
band
et
al
inhal
ibv
infect
respiratori
tissu
replic
mainli
upper
respiratori
tract
raj
jone
viru
dissemin
tissu
epitheliotrop
enter
epitheli
cell
primarili
respiratori
organ
tissu
move
reproduct
region
kidney
intestin
caus
perman
damag
dysfunct
infect
organ
ibv
consist
major
structur
protein
spike
membran
n
nucleoprotein
protein
cleav
form
associ
form
spike
viru
surfac
protein
shown
immunogen
ib
typic
control
serotypespecif
vaccin
either
liveattenu
kill
band
et
al
problem
ibv
differ
serotyp
even
variant
littl
crossprotect
vaccin
constant
evolut
new
variant
caus
disappear
other
requir
constant
demand
new
serotyp
specif
vaccin
potenti
risk
revers
virul
liveattenu
vaccin
strain
weaker
immun
respons
subsequ
requir
multipl
dose
schedul
led
develop
recombin
vaccin
involv
express
protein
shown
stimul
viru
neutralis
cavanagh
et
al
research
carri
product
recombin
vaccin
band
et
al
includ
protein
product
use
baculoviru
express
system
song
et
al
well
recombin
fowl
adenoviru
johnson
et
al
shown
stimul
virusneutralis
antibodi
provid
protect
immun
chicken
zhou
et
al
shown
transgen
potato
tuber
extract
express
full
length
ibv
protein
induc
product
viru
neutralis
antibodi
provid
protect
chicken
challeng
live
ibv
addit
cell
mediat
immun
consid
contribut
protect
immun
ibv
also
stimul
measur
tcell
prolifer
increas
level
bluetongu
diseas
caus
bluetongu
viru
btv
belong
orbiviru
genu
reovirida
famili
sperlova
zendulkova
doublestrand
rna
viru
virion
doubl
capsid
compos
protein
shell
inner
layer
compos
capsid
protein
intermedi
layer
compos
capsid
protein
outer
layer
compos
capsid
protein
merten
et
al
noncontagi
infecti
diseas
affect
rumin
camelid
transmit
midg
culicoid
genu
differ
serotyp
record
maan
et
al
serotyp
recent
identifi
sequenc
jenckel
et
al
presenc
btv
first
record
south
africa
end
centuri
tradit
known
present
region
span
correspond
geograph
distribut
midg
respons
transmiss
carpent
et
al
becom
much
concern
recent
howev
due
global
warm
thought
favour
surviv
midg
colder
winter
period
thu
current
distribut
btv
outbreak
recent
shown
extend
beyond
previous
record
region
predict
broaden
africa
russia
unit
state
futureclim
predict
sami
peterson
bluetongu
affect
sheep
acut
chronic
subclin
condit
clinic
sign
usual
lame
swell
infertil
sever
case
death
goat
less
frequent
infect
rare
show
clinic
sign
diseas
although
symptom
less
sever
cattl
act
reservoir
host
clinic
sign
infect
rare
except
infect
btv
serotyp
report
caus
elev
number
morbid
fertil
mortal
elber
et
al
viru
introduc
anim
bite
infect
midg
direct
lymph
node
site
initi
viral
replic
viru
circul
blood
infect
secondari
organ
includ
addit
lymph
node
spleen
lung
pathogenesi
characteris
small
blood
vessel
injuri
target
tissu
lead
increas
vascular
permeabl
subsequ
oedema
effus
maclachlan
et
al
current
two
type
vaccin
avail
prophylact
immunis
anim
live
attenu
vaccin
inactiv
vaccin
vaccin
serotypespecif
import
establish
serotyp
respons
circul
specif
area
recent
live
attenu
vaccin
one
avail
multival
prepar
current
still
use
region
south
africa
although
effect
temperatur
sensit
show
poor
protect
heterolog
btv
serotyp
concern
howev
fact
vaccin
result
neg
clinic
sign
bluetongu
abort
reduct
milk
product
foetal
malform
pregnant
ewe
bhanuprakash
et
al
also
possibl
revers
virul
viral
reassort
could
gener
virul
strain
viru
sperlova
zendulkova
inactiv
vaccin
reliabl
protect
prevent
clinic
diseas
develop
fairli
expens
produc
anim
requir
revaccin
predominantli
use
variou
outbreak
experienc
europ
zientara
et
al
recombin
vaccin
could
help
abrog
use
live
inactiv
viru
provid
less
expens
altern
kill
vaccin
vaccin
includ
recombin
viral
vector
vaccin
subunit
vaccin
viruslik
particl
vlp
french
et
al
roy
abl
show
coexpress
btv
capsid
protein
insect
cell
use
baculoviru
express
system
result
product
assembl
vlp
major
immunogen
determin
present
outer
shell
inocul
anim
repres
btv
serotyp
show
immunogen
protect
stewart
et
al
btv
challeng
howev
product
scalabl
fairli
costli
implement
progress
develop
product
btv
serotyp
vlp
vaccin
plant
use
transient
express
n
benthamiana
thuenemann
et
al
van
zyl
et
al
btv
capsid
protein
clone
peaqht
express
vector
sainsburi
et
al
coinfiltr
n
benthamiana
leav
use
recombin
agrobacterium
four
protein
express
tem
analysi
purifi
extract
harvest
leav
show
protein
assembl
vlp
estim
yield
approxim
mg
vlp
per
kg
fresh
leaf
weight
purifi
prepar
vlp
per
dose
combin
ifa
inject
sheep
second
booster
dose
day
post
initi
inject
induc
strong
immun
respons
provid
protect
immun
sheep
challeng
btv
serotyp
strain
howev
method
purif
vlp
centrifug
scalabl
rift
valley
fever
rvf
zoonot
infecti
diseas
primarili
affect
rumin
caus
rift
valley
fever
viru
rvfv
first
identifi
rift
valley
kenya
caus
outbreak
diseas
sheep
rvfv
envelop
negativestrand
rna
viru
tripartit
genom
belong
phleboviru
genu
bunyavirida
famili
pepin
et
al
lipid
bilay
compos
glycoprotein
g
n
g
c
encapsid
rnaassoci
ribonucleoprotein
rnp
rna
polymeras
l
viru
restrict
subsaharan
africa
prior
middl
becom
endem
part
africa
arabian
peninsula
consid
emerg
viru
pepin
et
al
symptom
infect
rumin
vari
differ
anim
speci
includ
occurr
near
simultan
abort
pregnant
anim
high
neonat
mortal
hepat
damag
deform
young
rvfv
predominantli
spread
mosquito
although
harbour
vector
tick
sandfli
infect
anim
occur
predominantli
result
bite
mosquito
carri
viru
also
spread
direct
contact
infect
anim
tissu
fluid
main
rout
human
infect
sever
case
lead
jaundic
neurolog
diseas
haemorrhag
complic
possibl
fatal
pepin
et
al
spread
rvfv
prevent
vaccin
anim
human
develop
safe
effect
vaccin
difficult
bouloy
flick
ikegami
makino
live
attenu
vaccin
smithburn
strain
use
extens
livestock
vaccin
programm
still
caus
undesir
symptom
pregnant
anim
could
easili
revert
mutat
virul
strain
research
carri
use
inactiv
viral
strain
expens
produc
requir
multipl
dose
booster
immun
maintain
anim
formalininactiv
vaccin
use
veterinari
worker
endem
region
high
contain
lab
worker
other
high
risk
contract
rvfv
commerci
avail
use
veterinarian
work
area
endem
rvfv
well
other
high
risk
contract
diseas
includ
lab
worker
high
contain
area
like
live
attenu
vaccin
vaccin
expens
difficult
make
requir
multipl
dose
booster
efficaci
immun
make
routin
immunis
anim
impract
bouloy
flick
rvfv
glycoprotein
g
c
g
n
shown
antigen
determin
stimul
neutralis
antibodi
provid
immun
diseas
discoveri
enabl
sever
recombin
vaccin
candid
develop
express
vector
venezuelan
equin
enceph
veev
vector
lumpi
skin
diseas
viru
lsdv
vector
wallac
et
al
use
gener
rvfv
glycoprotein
elicit
rvfvspecif
immun
respons
provid
protect
rfvf
challeng
anim
rvfv
viru
like
particl
vlp
also
possibl
candid
vaccin
rvf
stabl
may
immunogen
recombin
protein
alon
maintain
conform
epitop
induc
neutralis
antibodi
express
rvfv
nucleocapsid
n
glycoprotein
g
n
g
c
togeth
dual
baculoviru
express
vector
liu
et
al
show
envelop
vlp
resembl
wildtyp
rvfv
virion
could
produc
vlp
also
produc
dual
baculoviru
vector
system
n
g
c
alon
vlp
pleomorph
vlp
compris
glycoprotein
habjan
et
al
produc
rvfv
vlp
mammalian
cell
coexpress
recombin
rvfv
polymeras
nucleocapsid
protein
togeth
minireplicon
rna
addit
express
viral
glycoprotein
habjan
et
al
shown
protect
mice
lethal
challeng
rvfv
et
al
interestingli
de
boer
et
al
shown
rvfv
vlp
produc
drosophila
insect
cell
system
express
g
n
g
c
protein
alon
furthermor
vlp
shown
provid
protect
mice
challeng
wildtyp
viru
type
vaccin
lack
n
protein
desir
help
distinguish
infect
vaccin
anim
diva
use
diagnost
kit
de
boer
et
al
also
test
effect
solubl
g
n
vaccin
mice
abl
show
full
protect
afford
lethal
challeng
rvfv
preliminari
studi
carri
immunogen
plantproduc
rvfv
antigen
kalbina
et
al
made
transgen
arabidopsi
plant
express
rvfv
g
n
delet
mutant
rvfv
n
kalbina
et
al
leav
contain
protein
fed
mice
oral
mous
serum
shown
elev
titr
antigenspecif
igg
suggest
immunogen
cchf
zoonot
diseas
caus
crimeancongo
haemorrhag
fever
viru
cchfv
belong
genu
nairoviru
famili
bunyavirida
whitehous
similar
rvfv
envelop
rna
viru
lipid
bilay
glycoprotein
g
n
g
c
encapsid
rnaassoci
ribonucleoprotein
rnp
polymeras
l
cchf
highli
contagi
diseas
infect
larg
varieti
vertebr
includ
sheep
goat
cattl
larg
wild
herbivor
hare
hedgehog
bent
et
al
also
numer
bird
speci
shown
antibodi
cchfv
although
refractori
infect
well
one
instanc
cchfv
antibodi
found
tortois
reptil
howev
anim
gener
show
symptom
diseas
develop
suffici
viraemia
support
transmiss
viru
uninfect
tick
bite
infect
human
distribut
diseas
tend
follow
geograph
rang
vector
human
host
cchfv
diseas
manifest
except
newborn
mice
human
also
becom
infect
handl
crush
infect
tick
direct
contact
infect
blood
tissu
anim
human
harbour
viru
diseas
endem
countri
africa
asia
southeast
europ
middl
east
recent
emerg
area
previous
free
diseas
turkey
cchf
notifi
diseas
outbreak
epidem
potenti
constitut
public
health
threat
high
fatal
ratio
nosocomi
outbreak
extrem
preval
viru
potenti
bioterror
agent
treatment
prevent
diseas
difficult
tick
harbour
cchfv
bite
anim
human
viru
transport
bloodstream
absorb
permiss
cell
bent
et
al
current
commerci
vaccin
avail
cchfv
howev
due
desir
vaccin
univers
accept
use
use
inocul
anim
main
carrier
viru
respons
diseas
outbreak
therebi
reduc
cchfv
number
within
popul
progress
made
develop
initi
formalininactiv
vaccin
develop
russia
suckl
mous
brain
human
hoogstraal
shown
induc
neutralis
antibodi
human
vaccin
licens
bulgaria
prophylact
use
peopl
work
armi
unit
medic
worker
agricultur
worker
peopl
live
cchf
endem
region
use
vaccin
report
reduc
cchf
case
bulgaria
christova
et
al
howev
vaccin
use
countri
europ
due
concern
product
mous
brain
may
induc
autoimmun
allerg
respons
human
addit
requir
maximum
contain
facil
gener
virion
inactiv
costli
anoth
type
treatment
use
russia
bulgaria
sever
countri
administr
anticchf
immunoglobulin
deriv
convalesc
serum
intramuscular
inject
intraven
keshtkarjahromi
et
al
cchf
patient
treat
convalesc
serum
recov
ill
despit
measur
vaccin
treatment
current
univers
accept
method
prophylaxi
cchf
much
work
done
prevent
cchfv
anim
develop
altern
vaccin
hamper
lack
inform
immunogen
epitop
cchfv
well
lack
cchf
anim
model
test
efficaci
use
newborn
mice
natur
affect
model
question
suscept
wide
array
pathogen
may
use
diseas
model
howev
recent
research
usa
yield
anim
model
potenti
use
test
vaccin
model
knockout
mice
model
sensit
cchfv
infect
keshtkarjahromi
et
al
encourag
develop
cchfv
vaccin
research
field
littl
research
altern
vaccin
platform
publish
zhou
et
al
report
product
cchf
n
protein
viru
like
particl
vlp
baculovirusinsect
cell
express
system
intent
test
immunogen
mice
spik
et
al
shown
dna
vaccin
contain
cchf
segment
encod
g
c
g
n
elicit
neutral
antibodi
vaccin
mice
well
antibodi
abl
react
g
n
g
c
protein
small
amount
work
conduct
product
cchfv
vaccin
candid
plant
ghiasi
et
al
report
product
cchfv
glycoprotein
g
n
g
c
transgen
tobacco
plant
serum
balbc
mice
oral
immunis
leav
root
contain
recombin
glycoprotein
combin
freund
adjuv
show
increas
antiglycoprotein
antibodi
although
ideal
model
diseas
rabbit
haemorrhag
fever
lethal
diseas
rabbit
caus
viru
rabbit
haemorrhag
diseas
viru
member
lagoviru
genu
calicivirida
famili
abrant
et
al
nonenvelop
rna
viru
outer
capsid
made
major
structur
protein
encapsid
sever
nonstructur
protein
includ
rnd
depend
polymeras
helicas
proteas
virion
extrem
resist
stabl
environ
caus
acut
necrotis
hepat
well
haemorrhag
organ
infect
caus
death
within
h
necrotis
hepat
outbreak
diseas
consequ
sever
effect
rabbit
meat
fur
industri
enter
oral
nasal
conjunctiv
rout
anim
usual
infect
host
cell
upper
respiratori
digest
tract
abrant
et
al
current
rabbit
vaccin
use
formalininactiv
liver
homogen
liverinfect
individu
rhv
capsid
protein
shown
immunogen
inject
recombin
baculovirusproduc
fusion
protein
shown
protect
immunis
rabbit
lethal
challeng
viru
hammond
nemchinov
fernandez
et
al
show
polypeptid
could
produc
nicotiana
clevelandii
use
plum
pox
potyviru
ppv
base
vector
et
al
rabbit
inject
subcutan
leaf
extract
contain
recombin
show
immun
respons
protect
intranas
challeng
rhdv
castanon
et
al
made
transgen
potato
plant
express
immunis
rabbit
parenter
leaf
extract
contain
recombin
mix
freund
adjuv
high
titr
measur
rabbit
serum
rabbit
fulli
protect
challeng
live
viru
addit
martinalonso
et
al
show
could
express
transgen
potato
tuber
yield
lg
per
mg
total
solubl
protein
tsp
oral
immunis
rabbit
lyophilis
potato
extract
contain
lg
per
dose
partial
effect
induc
immun
protect
rabbit
challeng
live
viru
coccidiosi
diseas
chicken
caus
protozoan
parasit
belong
eimeria
genu
shirley
et
al
diarrhoeal
diseas
caus
larg
poultri
loss
particularli
us
transmiss
parasit
via
oralfaec
rout
oocyst
eimeria
ingest
chicken
infect
gut
undergo
asexu
sexual
reproduct
phase
develop
oocyst
shed
faec
whereupon
undergo
meiosi
contact
oxygen
moistur
reingest
anim
sporozoit
releas
intestin
shirley
et
al
interestingli
infect
eimeria
shown
lead
lifelong
immun
particular
speci
eimeria
infect
host
henc
commerci
avail
live
attenu
vaccin
compris
specif
eimeria
genera
develop
routin
use
chick
hatcheri
price
although
crossprotect
shirley
et
al
howev
efficaci
stabil
issu
qualiti
control
cost
effect
make
live
attenu
vaccin
strain
led
develop
recombin
eimeriid
vaccin
highli
complex
natur
eimeriid
lifecycl
difficulti
identif
specif
antigen
protect
infect
well
method
deliveri
vaccin
present
problem
howev
develop
recombin
vaccin
shirley
et
al
date
studi
recombin
vaccin
antigen
associ
motil
function
import
parasit
cycl
stage
protein
associ
subcellular
organel
micronem
extens
studi
shivaramaiah
et
al
sathish
et
al
success
transient
express
e
tenella
micronem
mic
protein
n
tabacum
immunis
chick
adjuv
one
primari
boost
week
apart
show
stimul
high
serumspecif
igg
titr
well
induct
specif
respons
immunis
bird
also
challeng
show
increas
weight
compar
control
bird
group
also
produc
recombin
test
abil
stimul
immun
respons
bird
monoval
vaccin
well
combin
plantproduc
sathish
et
al
zimmerman
et
al
describ
develop
plantmad
recombin
antibodi
use
coccidiosi
identifi
antieimeria
scfv
mous
phage
display
librari
pan
protein
extract
variou
development
stage
parasit
scfvencod
gene
clone
vector
gener
transgen
pea
plant
vicia
fabafodd
pea
pea
seed
transgen
plant
dri
ground
forcef
chicken
infect
eimeria
contain
mg
scfv
pea
seed
flour
dose
sever
vaccin
candid
target
domest
anim
could
potenti
produc
plant
candid
discuss
chapter
success
produc
neutralis
antibodi
vaccin
anim
protect
anim
challeng
correspond
viru
suggest
plant
express
rout
could
potenti
product
vaccin
therebi
circumv
biosafeti
level
requir
live
viru
handl
well
problem
reassort
